Abstract
Results from the Treatment of Emphysema with a Selective Retinoid Agonist [TESRA; NCT00413205] study showed that emphysema patients had a mixed response to treatment with the retinoid agonist palovarotene. Treatment with palovarotene failed to meet the primary endpoint of improving lung function (FEV1) in the overall analysis.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
